Fall 2018 Vol. 08 Issue 03
-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Gathering PerspectiveA second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
-
Caregiving With Confidence
Make Your Mental Health a PriorityRecognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
-
Policy Matters
A Growing Commitment to Cancer SurvivorsThe number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
-
Moving Ahead
Cancer rehabilitation can help patients before and after treatment, but it's still not widely used.
by Cameron Walker
-
New Tactics for Bladder Cancer
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
-
Raising Their Voices
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
-
Survivor Profile
The Power of PatientsJanet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
-
Q&A
A Critical ConversationPalliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients' values guide end-of-life decisions.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersA patient support expert offers guidance on how to respond to news of a friend's cancer diagnosis.
-
Get Involved
Helping Kids CopeHelp with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
-
In the Moment- Fall 2018
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin